BRK-B vs HEQ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
The deterministic health profile is severely compromised, highlighted by a Piotroski F-Score of 1/9, indicating significant fundamental weakness. While the fund trades at a low P/E of 7.44, it is currently priced at a premium to its growth-based intrinsic value of $10.92. These red flags are partially offset by a strong dividend yield of 8.62% and impressive short-to-medium term price appreciation. Overall, the asset presents as a high-yield income vehicle with poor underlying financial health metrics.
Compare Another Pair
Related Comparisons
BRK-B vs HEQ: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and John Hancock Diversified Income Fund (HEQ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.